On common, folks with psychosis die 15 years sooner than the final inhabitants. That is largely as a consequence of preventable bodily diseases, with weight problems taking part in a central function (Plana-Ripoll O et al, 2019). Weight problems is round thrice extra widespread in folks with psychosis in comparison with the final inhabitants (Afzal M et al, 2021). Earlier analysis has proven that whereas antipsychotic medicines are important to assist restoration, they’re a key contributor to this concern (Johnston G, 2025; Pillinger T et al, 2020).
Prediction fashions like PsyMetRiC (Perry BI et al, 2026) are useful to determine threat of future bodily well being issues, which may inform younger folks with psychosis together with their medical groups. Nonetheless, these fashions will not be in a position to unravel what truly causes these points and the right way to stop them.
This new examine by Leighton et al. (2026) makes an attempt to bridge this hole. The authors explored whether or not early weight achieve within the first 12 weeks of antipsychotic remedy causes weight problems after 1 12 months, and whether or not we will use causal prediction fashions to grasp what would occur for a person if we intervened.
Understanding early weight achieve within the first weeks of antipsychotic remedy might assist stop long-term bodily well being inequalities in psychosis.
Strategies
This examine used knowledge from a randomised managed trial evaluating olanzapine and haloperidol in folks with first-episode psychosis.
The authors performed two most important analyses:
- Causal mediation evaluation (n=97) to check whether or not weight achieve at 1 12 months is mediated by early (0-12 weeks) versus later (12-52 weeks) weight change.
- Prediction modelling, growing two sequential logistic regression fashions:
- A baseline mannequin predicting ≥7% weight achieve at 12 weeks (n=172)
- A 12-week mannequin predicting weight problems at 1 12 months (n=97)
Additionally they used counterfactual modelling to estimate how altering remedy or early weight would possibly alter outcomes.
Outcomes
Pattern and outcomes
The baseline mannequin included 172 members. On this group, 57% skilled clinically important weight achieve (≥7%) at 12 weeks. The 12-week mannequin included 97 members, of whom 36% developed weight problems at 1 12 months.
Causal mediation
The whole impact of olanzapine in comparison with haloperidol on 1-year weight was 6.62 kg (95% CI 1.44 to 12.3). Most of this impact was defined by weight achieve within the first 12 weeks (5.70 kg; 95% CI 2.83 to eight.66). There was no sturdy proof that later weight achieve between 12-52 weeks performed a significant mediating function.
Total, long-term variations in weight seem like pushed largely by early adjustments relatively than later weight achieve.
Prediction mannequin efficiency
The fashions distinguished properly between folks with greater and decrease threat of clinically important weight achieve/weight problems. Nonetheless, their predictions are overly optimistic, showcasing patterns of under-estimating sufferers’ threat. Particularly:
- Baseline mannequin (12-week clinically important weight achieve):
- C-index: 0.728 (good discrimination)
- Calibration slope: 0.768 (some overfitting)
- 12-week mannequin (1-year weight problems):
- C-index: 0.904 (excellent discrimination)
- Calibration slope: 0.601 (notably overfitted)
Counterfactual predictions
Switching from olanzapine to haloperidol decreased threat of early weight achieve. Lowering weight achieve inside the first 12 weeks lowered predicted threat of growing weight problems inside 1 12 months.
Which means that if a affected person good points lots of weight early into remedy, intervening shortly might change their long-term trajectory.
Utilizing mediation evaluation and prediction modelling, the examine confirmed that early weight achieve within the first 12 weeks of remedy defined many of the distinction in longer-term weight outcomes.
Conclusions
The authors concluded that:
Early weight achieve within the first 12 weeks of antipsychotic remedy might causally mediate weight outcomes at 1 12 months.
Additionally they show the feasibility of causal prediction fashions, which may estimate how remedy adjustments or adjustments in early weight trajectories would possibly alter outcomes for people.
Nonetheless, these fashions will not be but prepared for medical use, as a consequence of small pattern sizes in mannequin growth and a scarcity of exterior validation. The findings are greatest seen as hypothesis-generating, pointing towards the potential of causal prediction modelling relatively than instruments for present medical decision-making.
Early weight trajectories might affect 1-year outcomes, however though causal prediction fashions are possible, they aren’t but prepared for apply.
Strengths and limitations
That is an bold and methodologically modern examine utilizing randomised managed trial knowledge. This reduces the impression of confounding by indication, the place clinicians in routine apply select remedies primarily based on affected person traits. As the identical traits might additionally affect outcomes, confounding by indication makes it troublesome to separate true remedy results from variations between sufferers. The usage of randomised trial knowledge on this examine helps stability these traits throughout remedy teams and due to this fact strengthens claims of causality, that means variations in outcomes usually tend to replicate the remedy itself relatively than pre-existing variations between sufferers.
Nonetheless, a number of points restrict the impression of those findings:
- The pattern is small, particularly for the 12-week and mediation analyses (n=97)
- There may be substantial, unbalanced dropout throughout the 2 arms.
- Miscalibration is seen in each fashions.
Collectively, these limitations elevate issues about attrition bias and overfitting, making it much less doubtless that this mannequin will generalise to different sufferers.
Extra typically, whereas causal prediction fashions supply a step ahead from conventional threat prediction, they themselves include necessary limitations. They depend on sturdy assumptions concerning the underlying causal construction: if these are incorrect, the ensuing predictions and advised interventions could also be deceptive. As such, these approaches require massive, high-quality datasets to precisely mannequin this causal construction. Nonetheless, this then implies that these datasets might not replicate real-world medical samples. Randomised managed trial knowledge solely characterize round 20% of individuals with psychosis, as many have bodily well being comorbidities that result in trial exclusion (Taipale H et al., 2022).
Causal prediction fashions additionally stay susceptible to unmeasured confounding (e.g. life-style or organic elements), which may bias estimates even in well-designed analyses (although the authors of the present paper mitigated this with sensitivity analyses).
A key problem is that counterfactual predictions, that are central to those fashions, can’t be instantly validated on the particular person stage. This limits confidence in individual-level “what if” medical eventualities.
This examine advantages from randomised knowledge for causal inference, however sensible and methodological limitations in modelling, generalisability, and unverifiable counterfactuals imply findings stay exploratory.
Implications for apply
So, what does this imply for real-world care?
1. Timing is the whole lot
Beginning antipsychotic remedy can shortly result in substantial weight achieve. This echoes earlier research displaying that individuals with first episode psychosis gained 3.5kg on common inside the first 35 days of remedy (Vochoskova Okay et al. 2023).
* The primary 12 weeks of antipsychotic remedy are essential *
If early weight achieve drives later weight problems, then ready months or years to intervene is just too late. Providers ought to prioritise:
- Early weight monitoring (weekly/fortnightly)
- Early entry to dietary or life-style help
- Proactive discussions about weight threat earlier than beginning medicine
2. Rethinking remedy selections
The findings additionally elevate questions on antipsychotic selection. Whereas olanzapine could also be simpler or higher tolerated in some instances, its metabolic dangers are substantial.
This examine suggests:
- Remedy selections ought to explicitly weigh psychiatric profit vs bodily well being dangers
- Shared decision-making is vital: sufferers ought to perceive these trade-offs and have enter through which unwanted side effects they view as most necessary to keep away from.
3. Towards precision psychiatry
Maybe essentially the most thrilling implication is the potential for causal, individualised prediction fashions. By means of use of causal prediction fashions, we will predict not simply threat, however what would occur if we intervened. This framework doesn’t must act in opposition with associative prediction fashions (e.g. PsyMetRiC), however might inform medical determination making to scale back the impression of recognized dangers and optimising take care of folks with psychosis.
Total, whereas the examine makes use of novel and acceptable strategies, the findings needs to be interpreted cautiously, as an alternative demonstrating the feasibility and the potential of causal prediction fashions in psychiatry.
Early antipsychotic remedy can quickly improve weight, highlighting the necessity for early monitoring, knowledgeable prescribing selections, and the potential function of prediction fashions in guiding personalised threat and remedy in psychosis care.
Assertion of pursuits
Dominic Oliver is a part of the PsyMetRiC Working Division in partnership with College of Birmingham Enterprise however derives no monetary profit. Generative AI was used for modifying functions.
Editor
Edited by Éimear Foley. AI instruments assisted with language refinement and formatting in the course of the editorial part.
Hyperlinks
Main paper
Samuel Leighton, I Lam Leong, Damian Machlanski, Benjamin Perry, Sotirios Tsaftaris, Fani Deligianni, Stephen Lawrie, Rajeev Krishnadas (2026) Antipsychotic-induced weight achieve in psychosis: causal mediation evaluation and feasibility examine of causal actionable prediction mannequin growth utilizing counterfactuals to focus on weight problems. British Journal of Psychiatry. Printed on-line 2026:1-10. doi:10.1192/bjp.2026.10561
Different references
Afzal M, Siddiqi N, Ahmad B et al. (2021) Prevalence of Obese and Weight problems in Individuals With Extreme Psychological Sickness: Systematic Evaluate and Meta-Evaluation. Entrance. Endocrinol. 12:769309. doi: 10.3389/fendo.2021.769309
Johnston G (2025) Speedy weight achieve after SMI analysis, however why so few referrals for help? The Psychological Elf, 2 Dec 2025.
Perry BI, Osimo EF, Si S. et al. (2026) Cardiometabolic prediction fashions for younger folks with psychosis spectrum issues within the UK (PsyMetRiC 2.0): a retrospective, multicohort medical prediction mannequin examine. Lancet Psychiatry 2026 13 (4) 291-303 https://doi.org/10.1016/S2215-0366(25)00398-0
Pillinger T, McCutcheon RA, Vano L. et al. (2020) Comparative results of 18 antipsychotics on metabolic operate in sufferers with schizophrenia, predictors of metabolic dysregulation, and affiliation with psychopathology: a scientific assessment and community meta-analysis. Lancet Psychiatry 2020 7 (1) 64-77. https://doi.org/10.1016/S2215-0366(19)30416-X
Plana-Ripoll O, Pedersen CB, Agerbo E, et al. A complete evaluation of mortality-related well being metrics related to psychological issues: a nationwide, register-based cohort examine. Lancet 2019; 394: 1827–35; DOI: 10.1016/S0140-6736(19)32316-5
Taipale H, Schneider-Thoma J, Pinzón-Espinosa J. et al. (2022) Illustration and outcomes of people with schizophrenia seen in on a regular basis apply who’re ineligible for randomized medical trials. JAMA Psychiatry 2022 79 (3) 210-218. https://doi.org/10.1001/jamapsychiatry.2021.3990
Vochoskova Okay, McWhinney SR, Fialova M, et al. Weight and metabolic adjustments in early psychosis-association with every day quantification of medicine publicity in the course of the first hospitalization. Acta Psychiatr Scand. 2023 148 265–276. https://doi.org/10.1111/acps.13594
